BDNF and psychiatric disorder: In any case, the efficiency of treatments enhancing or mimicking BDNF actions, or those directed to TrkB transactivation, could be dramatically limited if the receptor stability and function were aberrant, as is frequently the case in neurological and psychiatric disorders.